Oregon Rural Practice-based Research Network (ORPRN), Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Mail Code: L222, Portland, 97239, OR, USA.
Department of Family Medicine & OHSU-PSU School of Public Health, Oregon Health & Science University, Portland, OR, USA.
BMC Cancer. 2018 Jan 6;18(1):40. doi: 10.1186/s12885-017-3813-4.
Interventions to improve fecal testing for colorectal cancer (CRC) exist, but are not yet routine practice. We conducted this systematic review to determine how implementation strategies and contextual factors influenced the uptake of interventions to increase Fecal Immunochemical Tests (FIT) and Fecal Occult Blood Testing (FOBT) for CRC in rural and low-income populations in the United States.
We searched Medline and the Cochrane Library from January 1998 through July 2016, and Scopus and clinicaltrials.gov through March 2015, for original articles of interventions to increase fecal testing for CRC. Two reviewers independently screened abstracts, reviewed full-text articles, extracted data and performed quality assessments. A qualitative synthesis described the relationship between changes in fecal testing rates for CRC, intervention components, implementation strategies, and contextual factors. A technical expert panel of primary care professionals, health system leaders, and academicians guided this work.
Of 4218 citations initially identified, 27 unique studies reported in 29 publications met inclusion criteria. Studies were conducted in primary care (n = 20, 74.1%), community (n = 5, 18.5%), or both (n = 2, 7.4%) settings. All studies (n = 27, 100.0%) described multicomponent interventions. In clinic based studies, components that occurred most frequently among the highly effective/effective study arms were provision of kits by direct mail, use of a pre-addressed stamped envelope, client reminders, and provider ordered in-clinic distribution. Interventions were delivered by clinic staff/community members (n = 10, 37.0%), research staff (n = 6, 22.2%), both (n = 10, 37.0%), or it was unclear (n = 1, 3.7%). Over half of the studies lacked information on training or monitoring intervention fidelity (n = 15, 55.6%).
Studies to improve FIT/FOBT in rural and low-income populations utilized multicomponent interventions. The provision of kits through the mail, use of pre-addressed stamped envelopes, client reminders and in-clinic distribution appeared most frequently in the highly effective/effective clinic-based study arms. Few studies described contextual factors or implementation strategies. More robust application of guidelines to support reporting on methods to select, adapt and implement interventions can help end users determine not just which interventions work to improve CRC screening, but which interventions would work best in their setting given specific patient populations, clinical settings, and community characteristics.
In accordance with PRISMA guidelines, our systematic review protocol was registered with PROSPERO, the international prospective register of systematic reviews, on April 16, 2015 (registration number CRD42015019557 ).
改善结直肠癌(CRC)粪便检测的干预措施已经存在,但尚未成为常规实践。我们进行了这项系统评价,以确定实施策略和背景因素如何影响提高美国农村和低收入人群粪便免疫化学检测(FIT)和粪便潜血检测(FOBT)对 CRC 的干预措施的采用。
我们从 1998 年 1 月到 2016 年 7 月在 Medline 和 Cochrane 图书馆,以及从 2015 年 3 月到 2015 年在 Scopus 和 clinicaltrials.gov 搜索了增加 CRC 粪便检测的干预措施的原始文章。两名评审员独立筛选摘要、审查全文文章、提取数据和进行质量评估。定性综合描述了 CRC 粪便检测率变化、干预组成部分、实施策略和背景因素之间的关系。一组初级保健专业人员、卫生系统领导人以及学术专家的技术专家小组指导了这项工作。
最初确定的 4218 条引文中有 27 条符合纳入标准,分别发表在 29 篇出版物中。研究在初级保健(n=20,74.1%)、社区(n=5,18.5%)或两者(n=2,7.4%)环境中进行。所有研究(n=27,100.0%)均描述了多组分干预措施。在基于诊所的研究中,在高度有效/有效的研究臂中最常出现的组件是通过直接邮件提供试剂盒、使用预贴邮票的信封、客户提醒和提供者在诊所内分发。干预措施由诊所工作人员/社区成员(n=10,37.0%)、研究人员(n=6,22.2%)、两者(n=10,37.0%)或不清楚(n=1,3.7%)提供。超过一半的研究缺乏关于培训或监测干预措施保真度的信息(n=15,55.6%)。
改善农村和低收入人群 FIT/FOBT 的研究采用了多组分干预措施。通过邮件提供试剂盒、使用预贴邮票的信封、客户提醒和在诊所内分发,在高度有效/有效的基于诊所的研究臂中最常出现。很少有研究描述了背景因素或实施策略。更有力地应用指南来支持选择、适应和实施干预措施的方法报告,可以帮助最终用户不仅确定哪些干预措施可用于改善 CRC 筛查,还可以确定在特定的患者群体、临床环境和社区特征下,哪些干预措施在其环境中最有效。
根据 PRISMA 指南,我们的系统评价方案于 2015 年 4 月 16 日在 PROSPERO(国际系统评价前瞻性注册库)上进行了注册,注册号为 CRD42015019557。